Cargando…
Application of lymphoplasmapheresis in the treatment of severe myasthenia gravis
BACKGROUND: Lymphoplasmapheresis (LPE) is a treatment that combines traditional plasma exchange and lymphocyte removal technique. It has been applied to treat a variety of autoimmune diseases, but its application value in the treatment of severe myasthenia gravis (MG) is not yet clear. Therefore, th...
Autores principales: | Duan, Weiwei, Zhou, Hao, Dong, Xiaohua, Li, Bijuan, Li, Yi, Cai, Haobing, Zhou, Qian, Ouyang, Song, Yin, Weifan, Yang, Huan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595276/ https://www.ncbi.nlm.nih.gov/pubmed/36303555 http://dx.doi.org/10.3389/fneur.2022.1018509 |
Ejemplares similares
-
Lymphoplasmapheresis versus plasma exchange in severe myasthenia gravis: a retrospective cohort study
por: Duan, Weiwei, et al.
Publicado: (2023) -
Lymphoplasma Exchange Improves Myasthenia Gravis Exacerbations: A Retrospective Study in a Chinese Center
por: Ouyang, Song, et al.
Publicado: (2022) -
Editorial: Phenotypes of myasthenia gravis
por: Li, Hai-Feng, et al.
Publicado: (2022) -
Afterdischarges in Myasthenia Gravis
por: Yang, Li, et al.
Publicado: (2021) -
Evaluation of the Quantitative Myasthenia Gravis Score and Grip Strength in Chinese Patients With Myasthenia Gravis: An Observational Study
por: Li, Jinghao, et al.
Publicado: (2021)